231 related articles for article (PubMed ID: 35116544)
1. Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis.
Li Y; Chen P; Chen Z
Transl Cancer Res; 2021 May; 10(5):2265-2276. PubMed ID: 35116544
[TBL] [Abstract][Full Text] [Related]
2. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang Z; Chen P; Xie H; Cao P
Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
Li JJ; Lv Y; Ji H
PeerJ; 2022; 10():e14303. PubMed ID: 36348665
[TBL] [Abstract][Full Text] [Related]
4. Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis.
Zhang C; Chao F; Wang S; Han D; Chen G
J Oncol; 2022; 2022():1505087. PubMed ID: 35669243
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer.
He X; Chi Y; Peng J; Hu W; Ding C; Li B
J Thorac Dis; 2022 Jun; 14(6):2103-2111. PubMed ID: 35813759
[TBL] [Abstract][Full Text] [Related]
6. Detection of Circulating Cell-Free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-Analysis.
Aalami AH; Aalami F; Aliabadi EK; Amirabadi A; Sahebkar A
Curr Med Chem; 2023 Jun; ():. PubMed ID: 37349993
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li B; Pu K; Ge L; Wu X
Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis.
Yu D; Tong Y; Guo X; Feng L; Jiang Z; Ying S; Jia J; Fang Y; Yu M; Xia H; Shi L; Lou J
Front Oncol; 2019; 9():95. PubMed ID: 30881916
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis.
Zhao QT; Guo T; Wang HE; Zhang XP; Zhang H; Wang ZK; Yuan Z; Duan GC
Onco Targets Ther; 2015; 8():3433-9. PubMed ID: 26640383
[TBL] [Abstract][Full Text] [Related]
10. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract][Full Text] [Related]
11. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
Zhang WT; Zhang GX; Zhao RZ; Gao SS
Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
[TBL] [Abstract][Full Text] [Related]
12. Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.
Liao W; Mao Y; Ge P; Yang H; Xu H; Lu X; Sang X; Zhong S
Medicine (Baltimore); 2015 Apr; 94(14):e722. PubMed ID: 25860220
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.
Xie W; Xie L; Song X
Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: A meta-analysis.
Wu Q; Bai SN; Song LY; Wu WF; Han LN
Medicine (Baltimore); 2023 Aug; 102(33):e34737. PubMed ID: 37603503
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis.
Chang Y; Jeong SW; Jang JY; Eun H; Lee YS; Song DS; Yu SJ; Lee SH; Kim W; Lee HW; Kim SG; Ryu S; Park S
J Liver Cancer; 2022 Sep; 22(2):167-177. PubMed ID: 37383408
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 and microRNA-30c as diagnostic biomarkers for prostate cancer: a meta-analysis.
Zhou H; Zhu X
Cancer Manag Res; 2019; 11():2039-2050. PubMed ID: 30881128
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of cell-free DNA in thyroid cancer: A systematic review and meta-analysis.
Hou F; Sun XD; Deng ZY
Medicine (Baltimore); 2023 Feb; 102(7):e32928. PubMed ID: 36800605
[TBL] [Abstract][Full Text] [Related]
18. Liquid Biopsy as Surrogate to Tissue in Lung Cancer for Molecular Profiling: A Meta-Analysis.
Mlika M; Dziri C; Zorgati MM; Ben Khelil M; Mezni F
Curr Respir Med Rev; 2018 Mar; 14(1):48-60. PubMed ID: 30271314
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of CT texture analysis for differentiating low-grade and high-grade renal cell carcinoma: systematic review and meta-analysis.
Yu W; Liang G; Zeng L; Yang Y; Wu Y
BMJ Open; 2021 Dec; 11(12):e051470. PubMed ID: 34937716
[TBL] [Abstract][Full Text] [Related]
20. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
